Skip to content
Head to head

Medtronic vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: MDT · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

MDT +6.4%ABT -19.3%
Medtronic edges it on the scoreable measures. Medtronic has the highest Quant Rating (42); Medtronic has done best over the past year (+3%); Medtronic trades cheapest on trailing earnings.
MDTABT
Snapshot
SectorMedical DevicesMedical Devices
Last price99.94103.00
Change today-0.67%-0.84%
1-year return+3.1%-15.4%
Market cap$127.84B$178.39B
52-week range72.06 – 106.2080.89 – 126.70
Valuation
P/E (TTM)24.6238.29
P/E percentile, own 5-yr range33rd99th
P/B2.543.50
Dividend yield2.85%2.41%
Profitability & growth
EPS (TTM)3.733.72
Net profit (TTM)$4.77B$6.44B
Revenue (TTM)$37.54B$48.23B
Provider revenue period date2026-07-302026-09-29
Revenue growth (YoY)+13.7%+14.5%
Gross margin65.0%56.9%
Operating margin19.0%13.8%
Net margin13.9%9.7%
Free cash flow (TTM)$6.13B$6.76B
Provider cash-flow period date2026-07-302026-09-29
Ownership & sentiment
Institutional ownership95.7%81.2%
Insider activity (12mo)27 buy / 18 sell36 buy / 12 sell
Short interest (% of float)1.8%1.1%
Analyst consensus60% buy / 40% hold (20)93% buy / 7% hold (15)
Analyst price target$107 (+7%)$122 (+18%)
StockVane view
StockVane Quant RatingC (42)D (22)
Company
Employees95,000115,000
Founded19491900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.